₹198.45
−4.98%NSE close, 16 Nov 2026
−21.16%
Ennature Bio Pharma is a small cap company in the Healthcare sector, listed on NSE under the symbol ENNATURE. At ₹198.45 a share, the market values the whole company at ₹443 crore.
Companies of a similar size in the same sector include Trident Lifeline, TRANSCHEM, Prevest Denpro and ASTONEA LABS.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | Sep 2026 |
|---|---|
| Sales | 78.5 |
| Expenses | 68.1 |
| Operating profit | 10.3 |
| Operating margin | 13.2% |
| Other income | 0 |
| Interest | 0.0 |
| Depreciation | 3.7 |
| Profit before tax | 6.6 |
| Tax | 1.7 |
| Net profit | 4.9 |
| EPS (₹) | 2.19 |
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Ennature Bio Pharma | ₹198.45 | ₹443 cr | n/a | n/a | n/a | n/a |
| Trident Lifeline | ₹422.00 | ₹505 cr | n/a | n/a | n/a | +37.93% |
| TRANSCHEM | ₹411.45 | ₹504 cr | n/a | n/a | n/a | +505.07% |
| Prevest Denpro | ₹382.50 | ₹459 cr | n/a | n/a | n/a | −25.66% |
| ASTONEA LABS | ₹385.00 | ₹405 cr | n/a | n/a | n/a |
Outcome of Board Meeting
The Amendment to AOA/MOA of the company.
The financial results for the period ended September 30, 2026.
₹ crore, financial years to March.
Not filed yet.
₹ crore, at each year's end and the latest half year.
| Line | Sep 2026 |
|---|---|
| Shareholders’ equity | 532 |
| Borrowings | 0 |
| Total liabilities | 173 |
| Fixed assets | 537 |
| Investments | 0 |
| Cash and equivalents | 0.3 |
| Total assets | 705 |
₹ crore, by financial year, and the latest half year.
| Line | 6M to Sep 2026 |
|---|---|
| From operations | 12.6 |
| From investing | −4.2 |
| From financing | −8.3 |
| Spent on fixed assets | −4.2 |
| Free cash flow | 8.4 |
Margins, returns, debt, tax and cash.
Not filed yet.
| +146.79% |
| ASARFI HOSPITAL | ₹193.50 | ₹381 cr | n/a | n/a | n/a | +32.53% |
|---|
| ASTAL LABORATORIES | ₹65.40 | ₹286 cr | n/a | n/a | n/a | −31.63% |
|---|
| Accretion Nutraveda | ₹345.00 | ₹250 cr | n/a | n/a | n/a | n/a |
|---|
| Hannah Joseph Hospital | ₹107.80 | ₹245 cr | n/a | n/a | n/a | n/a |
|---|
Please find attached